Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by DexCom, Inc.

< Previous 1 2 3 4 Next >
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Appoints Jon Coleman as Chief Commercial Officer
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Appoints Renée Galá to Board of Directors
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom and ŌURA Announce Strategic Partnership
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Third Quarter 2024 Financial Results
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
From Dexcom, Inc.
Via Business Wire
Tickers DXCM
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
From DexCom, Inc.
Via Business Wire
Tickers DXCM
Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program
From DexCom, Inc.
Via Business Wire
Tickers DXCM
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.